GIRK-SPECIFIC DRUGS RESCUE ALTERED CHANNEL ACTIVITY IN GNB1 ENCEPHALOPATHY

• Haritha Reddy,
• Daniel Yakubovitch,
• Tal Raifman,
• Maria Pederson,
• Boris Shalomov,
• Jonathan Javitch,
• Amal Bera,
• Nathan Dascal

Affiliations

Haritha Reddy

Tel Aviv University, Physiology And Pharmacology, Tel Aviv, Israel

Daniel Yakubovitch

Ariel University, The Adelson School Of Medicine, Ariel, Israel

Tal Raifman

Tel Aviv University, Physiology And Pharmacology, Tel Aviv, Israel

Maria Pederson

New York Genome Center, Center For Neurodegenerative Diseases, New York, United States of America

Boris Shalomov

Tel Aviv University, Physiology And Pharmacology, Tel Aviv, Israel

Jonathan Javitch

Columbia University, Departments Of Psychiatry & Molecular Pharmacology And Therapeutics, New York, United States of America

Amal Bera

Indian Institute of Technology Madras, Biotechnology, Chennai, India

Nathan Dascal

Tel Aviv University, Physiology And Pharmacology, Tel Aviv, Israel